CHARLOTTE, N.C.--(BUSINESS WIRE)--Catawba Research, a leading clinical research organization with a goal to become the world’s most trusted CRO, is announcing changes to its executive leadership team. Effective today, Catawba’s Founder, Zaidoon A. Al-Zubaidy, is transitioning his day-to-day leadership responsibilities to Dr.

北卡罗来纳州夏洛特（BUSINESS WIRE）-Catawba Research是一家领先的临床研究组织，旨在成为世界上最受信任的CRO，宣布对其执行领导团队进行变革。自今天起，Catawba的创始人Zaidoon A.Al-Zubaidy正在将他的日常领导责任转变为Dr。

Andy Silverman. Al-Zubaidy will become executive chairman where he will support customer relationships and provide mentorship to the executive leadership team. Silverman will expand his responsibilities from operational leadership as chief operating officer (COO) to driving the entire organization to meet its growth targets as the chief executive officer (CEO)..

安迪·西尔弗曼。Al-Zubaidy将成为执行主席，他将支持客户关系并为执行领导团队提供指导。西尔弗曼将扩大其作为首席运营官（首席运营官）的运营领导的职责，以推动整个组织实现其作为首席执行官（首席执行官）的增长目标。。

Silverman was recruited to Catawba by Liberty Lane Partners because of his extensive background in clinical research built off a 30-year career with PPD, INC Research and Syneos Health. “Since joining the firm in early 2022, Andy has exceeded our expectations at every step. He has been instrumental in establishing market leading operational capabilities at Catawba that have positioned the company for its next phase of growth.

Silverman被Liberty Lane合作伙伴招募到Catawba，因为他在PPD，INC research和Syneos Health公司30年的职业生涯中建立了广泛的临床研究背景。“自2022年初加入该公司以来，Andy在每一步都超出了我们的预期。他一直在Catawba建立市场领先的运营能力，为公司的下一个增长阶段奠定了基础。

His leadership has made an impact on all stakeholders and given us confidence that he will succeed in his expanded role,” said Nick Goldstein, managing director of Liberty Lane Partners..

他的领导层对所有利益相关者产生了影响，并使我们相信他将在扩大的角色中取得成功，”Liberty Lane Partners总经理尼克·戈尔茨坦（Nick Goldstein）说。。

“I am honored to be appointed CEO of Catawba Research,” said Silverman. “Building on the remarkable foundation that Zaidoon and our dedicated team have established, we will continue our mission to drive innovation in clinical research and deliver agile solutions across an evolving portfolio of therapeutic areas to our clients and partners.”.

西尔弗曼说：“我很荣幸被任命为Catawba Research的首席执行官。”。“在Zaidoon和我们的专业团队建立的卓越基础上，我们将继续我们的使命，推动临床研究创新，并为我们的客户和合作伙伴提供跨越不断变化的治疗领域组合的敏捷解决方案。”。

As Executive Chairman, Al-Zubaidy will ensure Catawba maintains its dedication to its core values as it grows. “I am extremely proud of Catawba Research’s accomplishments since our founding in 2014. And I look forward to serving as a mentor and partner to our seasoned executive team as we pursue our next leg of growth,” said Al-Zubaidy.

作为执行主席，Al-Zubaidy将确保Catawba随着其发展保持对核心价值的奉献。“自2014年成立以来，我为Catawba Research的成就感到极为自豪。Al-Zubaidy说，当我们追求下一步的发展时，我期待成为经验丰富的执行团队的导师和合作伙伴。

“While I’ll be stepping away from day-to-day operations, I will make sure Catawba remains an agile, responsive and trusted partner to our sponsors. I am extremely confident with Andy’s leadership and vision, we will continue our outstanding history of delivering excellence in clinical research services.”.

“虽然我将远离日常运营，但我将确保Catawba仍然是我们赞助商的敏捷，响应和可信的合作伙伴。我对Andy的领导和愿景充满信心，我们将继续我们卓越的历史提供卓越的临床研究服务“。

Please join us on this journey and wish Andy the best of luck in his new role.

请和我们一起参加这次旅程，并希望Andy在他的新角色中获得最好的运气。

About Catawba Research

关于Catawba研究

Catawba Research is a leading contract research organization specializing in clinical research and development services for the pharmaceutical, biotechnology, and medical device industries. With a strong commitment to quality, innovation, and client satisfaction, Catawba Research delivers comprehensive solutions to advance healthcare products from concept to market.

Catawba Research是一家领先的合同研究组织，专门为制药，生物技术和医疗器械行业提供临床研究和开发服务。凭借对质量，创新和客户满意度的坚定承诺，Catawba Research提供全面的解决方案，将医疗产品从概念推向市场。

For more information, please visit www.catawbaresearch.com..

欲了解更多信息，请访问www.catawbaresearch.com。。